Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Ebrahim Barkoudah, M.D.


This page shows the publications co-authored by Ebrahim Barkoudah and Larry Weinrauch.
Connection Strength

  1. Wisely Choosing: Aging, Precision, and Medicine. Am J Med. 2018 02; 131(2):e63.
    View in: PubMed
    Score: 0.723
  2. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus. Ann Intern Med. 2016 08 02; 165(3):225.
    View in: PubMed
    Score: 0.652
  3. Screening for Type 2 Diabetes Mellitus. Ann Intern Med. 2015 Nov 03; 163(9):726.
    View in: PubMed
    Score: 0.619
  4. Getting lost among the guidelines: the difference between patient-focused treatment and population management. Am J Med. 2015 Oct; 128(10):e73.
    View in: PubMed
    Score: 0.615
  5. Letter by Weinrauch and Barkoudah Regarding Article, "Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation. Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry". Circulation. 2015 Feb 03; 131(5):e335.
    View in: PubMed
    Score: 0.588
  6. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med. 2016 Apr 21; 374(16):1521-32.
    View in: PubMed
    Score: 0.159
  7. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013 Mar 28; 368(13):1210-9.
    View in: PubMed
    Score: 0.129
  8. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA. 2013 Mar 20; 309(11):1125-35.
    View in: PubMed
    Score: 0.065
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.